These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 7907791

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Specificity versus redundancy of melanocortins in nerve regeneration.
    Antonawich FJ, Azmitia EC, Kramer HK, Strand FL.
    Ann N Y Acad Sci; 1994 Oct 31; 739():60-73. PubMed ID: 7832497
    [Abstract] [Full Text] [Related]

  • 3. The ACTH-(4-9) analogue ORG 2766 facilitates denervation supersensitivity after a unilateral 6-OHDA lesion of the corpus striatum in rats.
    Vos PE, Bluemink GJ, Wolterink G, Van Ree JM.
    Neuropeptides; 1991 Aug 31; 19(4):271-9. PubMed ID: 1656311
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
    Tang FI, Tien LT, Zhou FC, Hoffer BJ, Wang Y.
    Exp Brain Res; 1998 Apr 31; 119(3):287-96. PubMed ID: 9551829
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C, Kirik D, Björklund A.
    Exp Neurol; 2000 Feb 31; 161(2):503-16. PubMed ID: 10686072
    [Abstract] [Full Text] [Related]

  • 15. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.
    Opacka-Juffry J, Ashworth S, Hume SP, Martin D, Brooks DJ, Blunt SB.
    Neuroreport; 1995 Dec 29; 7(1):348-52. PubMed ID: 8742486
    [Abstract] [Full Text] [Related]

  • 16. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B, Kozlowski DA, Unnerstall JR, Elsworth JD, Tillerson JL, Schallert T, Bohn MC.
    Exp Neurol; 2001 May 29; 169(1):83-95. PubMed ID: 11312561
    [Abstract] [Full Text] [Related]

  • 17. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA, Beck KD, Araujo DM, Irwin I, Langston JW, Hefti F.
    Neuroscience; 1993 Apr 29; 53(3):639-50. PubMed ID: 8098137
    [Abstract] [Full Text] [Related]

  • 18. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo.
    Kearns CM, Gash DM.
    Brain Res; 1995 Feb 20; 672(1-2):104-11. PubMed ID: 7749731
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.